Showing 1,581 - 1,600 results of 3,491 for search '"Stem Cell"', query time: 0.13s Refine Results
  1. 1581
  2. 1582
  3. 1583
  4. 1584
  5. 1585
  6. 1586
  7. 1587
  8. 1588
  9. 1589
  10. 1590
  11. 1591
  12. 1592

    How to get over with medication errors underestimation? Improving indices of medication errors with focus on intravenous medications in hematopoietic stem cell transplantation setting; a direct observation study. by Ava Mansouri, Kiana Moazzeni, Maryam Valeh, Kazem Heidari, Molouk Hadjibabaie

    Published 2024-01-01
    “…Especially, in the hematopoietic stem cell transplantation (HSCT) setting where toxic drugs are frequently used and patients are in critical immunocompromised conditions, medication errors (ME) can have catastrophic reactions and devastating outcomes such as death. …”
    Get full text
    Article
  13. 1593
  14. 1594
  15. 1595
  16. 1596
  17. 1597
  18. 1598

    Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation by Chen C, Qiu K, Chen J, Wang S, Zhang Y, Wang C, Li Y

    Published 2025-01-01
    “…This study aims to investigate the significance of the alteration of IC co-expression for evaluating the prognosis of AML patients following allogeneic hematopoietic stem cell transplantation (allo-HSCT).Patients and Methods: Quantitative real-time PCR (qRT-PCR) data of bone marrow (BM) samples from 62 de novo AML patients, including 37 patients who received allo-HSCT and 25 patients who received chemotherapy only, were used for prognostic analysis.Results: High expression of PD-1, PD-L1, PD-L2, CTLA-4, and LAG-3 was associated with poor overall survival (OS) in AML patients receiving allo-HSCT, while the expression levels of PD-1, PD-L2, CTLA-4, and LAG-3, other than PD-L1, were not significantly correlated with OS in AML patients receiving chemotherapy. …”
    Get full text
    Article
  19. 1599
  20. 1600